These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16547152)

  • 1. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
    Gelman IH; Gao L
    Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge.
    Ko HK; Guo LW; Su B; Gao L; Gelman IH
    PLoS One; 2014; 9(10):e111534. PubMed ID: 25356636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
    Lin X; Gelman IH
    Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
    Su B; Bu Y; Engelberg D; Gelman IH
    J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.
    Gelman IH; Lee K; Tombler E; Gordon R; Lin X
    Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
    Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
    Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W; Unger P; Miller L; Nelson J; Gelman IH
    Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
    Liu Y; Gao L; Gelman IH
    BMC Cancer; 2006 Apr; 6():105. PubMed ID: 16638134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The guanine nucleotide exchange factor Arhgef5 plays crucial roles in Src-induced podosome formation.
    Kuroiwa M; Oneyama C; Nada S; Okada M
    J Cell Sci; 2011 May; 124(Pt 10):1726-38. PubMed ID: 21525037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.
    Bu Y; Gao L; Gelman IH
    Int J Cancer; 2011 Apr; 128(8):1836-42. PubMed ID: 20568114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein.
    Xia W; Gelman IH
    Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion.
    Courtneidge SA; Azucena EF; Pass I; Seals DF; Tesfay L
    Cold Spring Harb Symp Quant Biol; 2005; 70():167-71. PubMed ID: 16869750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition.
    Su B; Zheng Q; Vaughan MM; Bu Y; Gelman IH
    Cancer Res; 2006 Jun; 66(11):5599-607. PubMed ID: 16740695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase SHP2 suppresses podosome rosette formation in Src-transformed fibroblasts.
    Pan YR; Cho KH; Lee HH; Chang ZF; Chen HC
    J Cell Sci; 2013 Jan; 126(Pt 2):657-66. PubMed ID: 23178938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells.
    Seals DF; Azucena EF; Pass I; Tesfay L; Gordon R; Woodrow M; Resau JH; Courtneidge SA
    Cancer Cell; 2005 Feb; 7(2):155-65. PubMed ID: 15710328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis.
    Gelman IH; Tombler E; Vargas J
    Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRSp53 mediates podosome formation via VASP in NIH-Src cells.
    Oikawa T; Okamura H; Dietrich F; Senju Y; Takenawa T; Suetsugu S
    PLoS One; 2013; 8(3):e60528. PubMed ID: 23555988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo.
    Blouw B; Seals DF; Pass I; Diaz B; Courtneidge SA
    Eur J Cell Biol; 2008 Sep; 87(8-9):555-67. PubMed ID: 18417249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.
    Guo LW; Gao L; Rothschild J; Su B; Gelman IH
    J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture.
    Lin X; Tombler E; Nelson PJ; Ross M; Gelman IH
    J Biol Chem; 1996 Nov; 271(45):28430-8. PubMed ID: 8910468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.